Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1939)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$553.24
Total Value
$221.30K
Shares Held After
40,513
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$551.76
Total Value
$198.64K
Shares Held After
40,913
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$551.03
Total Value
$552.68K
Shares Held After
41,273
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,357
Price
$550.06
Total Value
$746.43K
Shares Held After
42,276
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,300
Price
$548.74
Total Value
$713.36K
Shares Held After
43,633
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,086
Price
$548.01
Total Value
$1.14M
Shares Held After
44,933
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,234
Price
$547.03
Total Value
$1.22M
Shares Held After
47,019
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$545.93
Total Value
$414.90K
Shares Held After
49,253
% of Holdings
1.5%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
5,000
Price
$70.00
Total Value
$350.00K
Shares Held After
0
% of Holdings
100.0%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
1,258
Price
$15.01
Total Value
$18.88K
Shares Held After
129,354
% of Holdings
1.0%
Lite Strategy, Inc. (LITS)
Flynn James P — Director
Shares
25,000
Price
$0.86
Total Value
$21.39K
Shares Held After
125,000
% of Holdings
20.0%
Beta Bionics, Inc. (BBNX)
Jones Christy — Director
Shares
1,406
Price
$15.00
Total Value
$21.09K
Shares Held After
25,994
% of Holdings
5.1%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
30,000
Price
$21.42
Total Value
$642.68K
Shares Held After
59,992
% of Holdings
33.3%
BECTON DICKINSON & CO (BDX)
Garrison Michael David — EVP & Pres Med.Essntl&BioPharm
Shares
1,100
Price
$145.66
Total Value
$160.23K
Shares Held After
13,172
% of Holdings
7.7%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
23,067
Price
$71.67
Total Value
$1.65M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
119,244
Price
$71.67
Total Value
$8.55M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
3,460
Price
$71.67
Total Value
$247.97K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
145,417
Price
$71.67
Total Value
$10.42M
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
19,173
Price
$70.84
Total Value
$1.36M
Shares Held After
23,067
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
99,118
Price
$70.84
Total Value
$7.02M
Shares Held After
119,244
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
2,876
Price
$70.84
Total Value
$203.72K
Shares Held After
3,460
% of Holdings
45.4%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
120,873
Price
$70.84
Total Value
$8.56M
Shares Held After
145,417
% of Holdings
45.4%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
115,000
Price
$0.04
Total Value
$5.17K
Shares Held After
93,884,319
% of Holdings
0.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
11,223
% of Holdings
3.4%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
400
Price
$30.00
Total Value
$12.00K
Shares Held After
30,547
% of Holdings
1.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
114
Price
$14.98
Total Value
$1.71K
Shares Held After
169,556
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
6,979
Price
$14.60
Total Value
$101.89K
Shares Held After
169,670
% of Holdings
4.0%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
666
Price
$14.98
Total Value
$9.98K
Shares Held After
793,328
% of Holdings
0.1%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
40,679
Price
$14.60
Total Value
$593.91K
Shares Held After
793,994
% of Holdings
4.9%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
37,167
Price
$70.00
Total Value
$2.60M
Shares Held After
8,383
% of Holdings
81.6%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
6,431
Price
$29.66
Total Value
$190.74K
Shares Held After
890,809
% of Holdings
0.7%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
5,696
Price
$8.16
Total Value
$46.47K
Shares Held After
187,432
% of Holdings
2.9%
Hongchang International Co., Ltd (HCIL)
Lin Zhenzhu — Director
Shares
1,450
Price
$0.12
Total Value
$174.00
Shares Held After
62,258,082
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
30,774
Price
$21.13
Total Value
$650.25K
Shares Held After
1,106,036
% of Holdings
2.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
39,131
Price
$21.13
Total Value
$826.84K
Shares Held After
1,510,157
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
77,855
Price
$21.13
Total Value
$1.65M
Shares Held After
4,805,639
% of Holdings
1.6%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
173
Price
$99.98
Total Value
$17.30K
Shares Held After
613,589
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,235
Price
$99.98
Total Value
$123.48K
Shares Held After
3,461,521
% of Holdings
0.0%
Trulieve Cannabis Corp. (TRLV)
Rivers Kim A. — Director
Shares
380,000
Price
$8.47
Total Value
$3.22M
Shares Held After
2,313,724
% of Holdings
14.1%
Aditxt, Inc. (ADTX)
Takeover Time 2026 LLC — 10% Owner
Shares
3,420,439
Price
$0.02
Total Value
$68.41K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
320
Price
$275.10
Total Value
$88.03K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,290
Price
$274.12
Total Value
$353.61K
Shares Held After
320
% of Holdings
80.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,800
Price
$273.30
Total Value
$491.95K
Shares Held After
1,610
% of Holdings
52.8%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
3,422
Price
$9.06
Total Value
$31.00K
Shares Held After
792,546
% of Holdings
0.4%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,068
Price
$276.74
Total Value
$295.55K
Shares Held After
0
% of Holdings
100.0%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
117,592
Price
$54.47
Total Value
$6.41M
Shares Held After
559,399
% of Holdings
17.4%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP & Chairman, Partnering
Shares
32,408
Price
$54.11
Total Value
$1.75M
Shares Held After
676,991
% of Holdings
4.6%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
9,900
Price
$9.04
Total Value
$89.50K
Shares Held After
865,559
% of Holdings
1.1%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,292
Price
$276.26
Total Value
$356.93K
Shares Held After
0
% of Holdings
100.0%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,450
Price
$18.00
Total Value
$26.10K
Shares Held After
51,776
% of Holdings
2.7%
Showing 201–250 of 1939 transactions (page 5 of 39)